GC
MDT icon

Grimes & Company’s Medtronic MDT Stock Holding History

Grimes & Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14M Buy
179,580
+1,720
+1% +$139K 0.3% 63
2026
Q1 		$15.4M Sell
177,860
-1,659
-0.9% -$159K 0.43% 49
2025
Q4 		$17.2M Sell
179,519
-10,223
-5% -$993K 0.41% 50
2025
Q3 		$18.1M Sell
189,742
-16,083
-8% -$1.48M 0.45% 44
2025
Q2 		$17.9M Buy
205,825
+2,777
+1% +$236K 0.49% 44
2025
Q1 		$18.2M Buy
203,048
+11,417
+6% +$1.02M 0.56% 44
2024
Q4 		$15.3M Sell
191,631
-3,233
-2% -$280K 0.44% 53
2024
Q3 		$17.5M Sell
194,864
-3,986
-2% -$335K 0.47% 44
2024
Q2 		$15.7M Buy
198,850
+3,655
+2% +$300K 0.47% 49
2024
Q1 		$17M Buy
195,195
+8,146
+4% +$695K 0.52% 50
2023
Q4 		$15.4M Buy
187,049
+9,223
+5% +$703K 0.51% 47
2023
Q3 		$13.9M Buy
177,826
+4,375
+3% +$366K 0.54% 44
2023
Q2 		$15.3M Buy
173,451
+3,206
+2% +$276K 0.54% 43
2023
Q1 		$13.7M Buy
170,245
+15,475
+10% +$1.26M 0.56% 41
2022
Q4 		$12M Sell
154,770
-4,798
-3% -$389K 0.51% 42
2022
Q3 		$12.9M Buy
159,568
+14,348
+10% +$1.29M 0.67% 29
2022
Q2 		$13M Buy
145,220
+7,708
+6% +$781K 0.66% 32
2022
Q1 		$15.3M Buy
137,512
+10,922
+9% +$1.15M 0.8% 35
2021
Q4 		$13.1M Buy
126,590
+2,434
+2% +$282K 0.6% 49
2021
Q3 		$15.6M Buy
124,156
+493
+0.4% +$63.8K 0.68% 37
2021
Q2 		$15.3M Buy
123,663
+1,072
+0.9% +$135K 0.67% 37
2021
Q1 		$14.5M Buy
122,591
+2,135
+2% +$250K 0.7% 33
2020
Q4 		$14.1M Buy
120,456
+1,837
+2% +$202K 0.73% 33
2020
Q3 		$12.3M Buy
118,619
+6,716
+6% +$674K 0.79% 31
2020
Q2 		$10.3M Buy
111,903
+80
+0.1% +$7.67K 0.71% 35
2020
Q1 		$10.1M Buy
111,823
+83,963
+301% +$8.93M 0.92% 21
2019
Q4 		$3.16M Buy
27,860
+1,201
+5% +$132K 0.21% 89
2019
Q3 		$2.9M Sell
26,659
-93,102
-78% -$9.71M 0.21% 85
2019
Q2 		$11.7M Buy
119,761
+1,073
+0.9% +$98K 0.89% 24
2019
Q1 		$10.8M Buy
118,688
+4,454
+4% +$399K 0.85% 31
2018
Q4 		$10.4M Sell
114,234
-293
-0.3% -$27.4K 1.01% 19
2018
Q3 		$11.3M Buy
114,527
+2,108
+2% +$195K 0.9% 25
2018
Q2 		$9.62M Sell
112,419
-2,662
-2% -$222K 0.85% 32
2018
Q1 		$9.23M Buy
115,081
+2,945
+3% +$243K 0.89% 34
2017
Q4 		$9.05M Sell
112,136
-375
-0.3% -$30K 0.87% 32
2017
Q3 		$8.75M Sell
112,511
-203
-0.2% -$16.9K 0.93% 29
2017
Q2 		$10M Sell
112,714
-1,366
-1% -$115K 1.12% 22
2017
Q1 		$9.19M Sell
114,080
-461
-0.4% -$36K 1.01% 22
2016
Q4 		$8.16M Buy
+114,541
New +$9M 0.95% 26
2016
Q2 		– Sell
-2,887
Closed -$217K – 218
2016
Q1 		$217K Sell
2,887
-2,090
-42% -$157K 0.03% 178
2015
Q4 		$383K Buy
4,977
+59
+1% +$4.44K 0.05% 131
2015
Q3 		$329K Sell
4,918
-404
-8% -$29.8K 0.04% 140
2015
Q2 		$394K Sell
5,322
-279
-5% -$21.3K 0.06% 123
2015
Q1 		$437K Sell
5,601
-33,466
-86% -$2.54M 0.11% 101
2014
Q4 		$2.82M Sell
39,067
-34,954
-47% -$2.43M 0.73% 58
2014
Q3 		$4.59M Sell
74,021
-1,333
-2% -$84.8K 1.2% 30
2014
Q2 		$4.8M Sell
75,354
-336
-0.4% -$20.4K 1.26% 30
2014
Q1 		$4.66M Sell
75,690
-34,862
-32% -$2.03M 1.31% 30
2013
Q4 		$6.34M Buy
110,552
+5,701
+5% +$323K 1.9% 15
2013
Q3 		$5.58M Buy
104,851
+3,769
+4% +$203K 1.89% 17
2013
Q2 		$5.2M Buy
+101,082
New +$5M 1.9% 17

Other funds holding MDT

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Grimes & Company's MDT Position: Q2 2026 in Review

Grimes & Company increased its Medtronic (MDT) stake by 0.97% in Q2 2026, buying an estimated $139K and bringing the position to 179,580 shares worth $14M. The position accounts for 0.3% of the portfolio, ranked #63.

Grimes & Company first reported a position in MDT in Q2 2013 and has held it in 51 quarters since. The position peaked at $18.2M in Q1 2025. 901 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Grimes & Company held 179,580 shares of Medtronic worth $14M as of Q2 2026.
  • Grimes & Company bought 1,720 Medtronic shares in Q2 2026, an estimated $139K.
  • Medtronic made up 0.3% of Grimes & Company's portfolio in Q2 2026, its #63 holding.
  • Grimes & Company first reported a position in Medtronic in Q2 2013 and has held it in 51 quarters since.
  • Grimes & Company's Medtronic position peaked at $18.2M in Q1 2025.
  • 901 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.